Kairos Venture Investments, Llc
Venture capitalBeverly Hills · Pre-Seed–Series A · 13 people tracked
Find your way into Kairos Venture Investments, Llc
1,737 people in our graph share verified history with the Kairos Venture Investments, Llc team — schools, employers, funds. One of them is your warm intro.
Investment thesis
Kairos Ventures invests in ideas, patents, and businesses emerging from the world's top universities and scientists. The firm focuses on scientific and technology innovations with the potential to have a significant, world-changing impact. Led by a group of entrepreneurs with experience building diverse businesses, it positions itself at the intersection of leading financial, scientific, and entrepreneurial expertise, backing early-stage science-driven companies.
Source: firm website, verified Sep 15, 2026.
Team · 13 people
from the firm's website & public directories
Founder mafia
2 people who came through Kairos Venture Investments, Llc went on to found or lead other companies.
What they invest in
from 18 of 36 portfolio companiesBiotech ×11Healthtech ×6Deep Tech ×5Medical Devices ×5AI & Machine Learning ×4Hardware ×3New Materials ×3Advanced Manufacturing ×2
HQs:United States×15Greece×1
Who they back
founder profiles across 9 portfolio companiesFounding team size:solo founder×22 founders×33 founders×4
Investments · 36 tracked
founders shown can be your intro pathBy year:2019 · 12017 · 32016 · 15 dated
Actuate Therapeutics is a clinical-stage biopharmaceutical company developing elraglusib, a small-molecule GSK-3β inhibitor designed to treat difficult-to-treat cancers including pancreatic, melanoma, lung, and pediatric cancers through intravenous injection and oral tablet formulations.
BiotechFort Worth, US
Daniel Schmitt(President & Chief Executive Officer)Paul Lytle(Executive Officer)inAndrew Mazar(Executive Officer)
BoardTodd Thomson(Director)inRoger Sawhney(Director)Jason Keyes(Director)
Co-investorsIllinois VenturesBiosBios Partners
Amorphology manufactures high-precision metallic components using amorphous metals and bulk metallic glass technology, enabling lower-cost production of complex parts like gearboxes for industrial and precision engineering applications.
Advanced ManufacturingDeep TechNew Materials
Douglas Hofmann(Scientific Founder)Jim Demetriades(Chairman)inAlex Andrianopoulos(Chief Executive Officer)inGlenn Garrett(Chief Technology Officer)
Actinia develops radiation detector materials based on CsPbBr3 (perovskite) semiconductors to improve the resolution and reduce the dose of radiological imaging techniques such as SPECT, CT, and X-ray, with applications in medicine and security.
Deep TechMedical DevicesNew Materials
Mercouri Kanatzidis(Co-Founder)inDuck Young Chung(Co-Founder)in
BoardJosh Palmer(Acting Chief Executive Officer)in
Avvio AMEA develops kidney stone treatment technology for urological care, targeting patients and healthcare providers across Asia, the Middle East, and Africa.
BiotechHardwareHealthtechMedical DevicesSan Francisco, US
Marshall Stoller(Founder)Robert Grubbs, PhD (deceased)(Founder)Claire Mills, RDMS, RVT(Founder)Paul Molloy(CEO and Director)inBen Zadik(Executive Officer)Greg Johnstone(CFO)
Co-investorsGlobal Bridge Capital
Behavioral Signals develops emotion recognition AI technology that analyzes speech to detect human emotions and behaviors.
AI & Machine LearningEnterprise SoftwareSaaSSales TechAthens, GR
Alex Potamianos(Founder)Shrikanth Narayanan(Founder & Chief Scientist)in
Co-investorsIn-Q-TelPresto Ventures
.jpg)
Clearsense operates the 1Clearsense Platform, a healthcare data lakehouse that unifies and manages disparate data for health systems and presents it in simplified, actionable views.
AI & Machine LearningData & InfrastructureDigital HealthHealthtechSaaSJacksonville, US
Ken Misch(Chief Financial Officer and Chief Operating Officer)inJason Rose(Chief Executive Officer)inMatt Henderson(Chief Compliance Officer and General Counsel)Jonathan Cook(Chief Technology Officer)inWirick Glenn(Chief Commercial Officer)Eugene Scheurer(Executive Officer, Director)
Co-investorsHealth Catalyst CapitalHealthQuest Capital
Rancho Santa Margarita, US
Mark Pollard(Executive Officer, Director)Kenneth Charhut(Executive Officer, Director)Nikolai Liachenko(Director)
BoardJerry Pellizzon(Director)
Co-investorsKairos Venture Partners
Biopharmaceutical company using molecular biology to produce recombinant derivatives of botulinum neurotoxin for customized applications.
BiotechNew York, US
Charles Weiss(Director)Andre Gudger(Director)Philip A. Band(Executive Officer, Director)
BoardMargery Fischbein(Director)
Co-investorsNYU Innovation Venture Fund
Delpor develops subcutaneous implant devices that deliver therapeutic drugs over extended periods (6-12 months) for chronic condition treatment.
BiotechHealthtechMedical Devices
Co-investorsUlu Ventures
Foldax develops heart valve replacement technology leveraging polymer expertise and biologic design.
Advanced ManufacturingBiotechHealthtechMedical DevicesSalt Lake City, US
Frank Maguire(Executive Officer, Director)
BoardKen Charhut(Director)George Wallace(Director)Morteza Gharib(Director)Mory Gharib(Director)
Co-investorsAngel Physicians FundMemorialCare Innovation FundKairos Venture Partners
Holoclara develops therapeutics derived from symbiotic intestinal organisms (helminths) that modulate inflammation, metabolism, and tissue regeneration to address chronic disease, immune-related conditions, and aging.
BiotechHealthtechLongevity
Andrea Choe(CEO / Co-Founder)inPaul W. Sternberg(Co-Founder)inFrank C. Schroeder(Co-Founder)in
Co-investorsHorizons VenturesBOLD CapitalBold Capital PartnersFREEFLOWEndurance28
Clinical-stage biotech company developing small molecule agents modulating cellular differentiation for cancer and pigmentation disorders.
BiotechHaddonfield, US
Patrick T. Mooney(Executive Officer)in
BoardJames Demetriades(Director)Todd Thomson(Director)inMichael D. Poisel(Director)Chris Arendt(Director)
Co-investorsIA GlobalKairos Venture Partners
MattiQ accelerates materials science discovery using a platform for computational experimentation and design across energy, computing, transportation, and space industries.
AI & Machine LearningBiotechDeep TechNew MaterialsChicago, US
Chad A. Mirkin(Scientific Founder & Director)Dr. Andrey Ivankin(Co-Founder & CTO)Jeffrey Erhardt(Executive Officer, Director)Ben Schlatka(CEO & Director)inLouis Simpson(Director)
BoardQuinten Stevens(Director)
Co-investorsMaterial Impact
Charles Fan(Founder)in
Co-investorsCisco InvestmentsFoothill VenturesIntel CapitalLightspeed Venture PartnersTyche Partners
Neuro-Bio is a privately owned biotech focused on neurodegenerative diseases, developing diagnostic and therapeutic strategies for Alzheimer's disease.
BiotechHealthtechMedical Devices
AgTechSanta Monica, US
Frances Arnold(Director)inPeter Meinhold(Executive Officer)inPedro Coelho(Executive Officer)inCorey Huck(Executive Officer, Director)in
BoardGANESH KISHORE(Director)inALAN BOYCE(Director)
Co-investorsAliment CapitalPontifax AgTechSpruce Capital PartnersVivo CapitalKairos Venture PartnersXeraya Capital
Pterodynamics develops the Transwing, an aircraft designed to support businesses seeking to reduce their operational environmental impact.
CleantechDefense TechHardwareRoboticsMoorpark, US
Matthew Graczyk(CEO)in
Co-investorsLavrock Ventures
Spectera Aerospace develops propulsion and flight systems for the aerospace industry.
Deep TechDefense TechHardwareSpace TechBoston, US
Felipe Gomez del Campo(Founder)in
Co-investorsE2MC VenturesEvergreen Climate Innovationsfutureland venturesOPAMP CAPITAL
Vivodyne is a bio-AI company that develops lab-grown human tissues and robotic systems to generate causal biological data for therapeutic development.
AI & Machine LearningBiotechDeep TechBrisbane, US
Andrei Georgescu(Executive Officer, Director)inDongeun Huh(Executive Officer, Director)Andrei Georgescu, Ph.D.(Founder)in
BoardQuinten Stevens(Director)Alex Andrianopolous(Director)Alex Morgan(Director)in
Co-investorsBison VenturesKhosla VenturesFortius VenturesMBX Capital
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
1200 PharmaAxial TherapeuticsDEARhealthGuRuKMLabsMidIRMixCommNanoClearnFugueNVasc, Inc.Pinpoint TherapeuticsPomeloQuicksilver BiosciencesSymbiotix BiotherapiesTPSTransient Plasma Systems (TPS)Wonder Blades
Exits · 3
1 IPOs · 2 acquisitionsActuate TherapeuticsNASDAQ: ACTUDEARhealthacq. by TopicusMixCommacq. by Sivers Semiconductors
Portfolio news
latest coverage across their companies
Actuate Therapeutics · stocktitan.net · Aug 14, 2026
Provivi · trysignalbase.com · Jun 11, 2026
Linnaeus Therapeutics · technical.ly · Mar 10, 2026
Mattiq · cen.acs.org · Nov 10, 2025
Holoclara · holoclara.com · Aug 28, 2025
Vivodyne · pci.upenn.edu · Jul 8, 2025
Avvio Medical · avviomedical.com · Jun 19, 2025
Frequently asked questions
- How many investments has Kairos Venture Investments, Llc made?
- Kairos Venture Investments, Llc has 36 tracked investments, 3 of which have exited.
- What stage does Kairos Venture Investments, Llc invest at?
- Kairos Venture Investments, Llc invests at the Pre-Seed, Seed, Series A stages.
- What is Kairos Venture Investments, Llc's typical check size?
- Kairos Venture Investments, Llc typically writes checks of $150K – $20M.
- What sectors does Kairos Venture Investments, Llc focus on?
- Kairos Venture Investments, Llc focuses on Biotech, Deep Tech, Energy, Medical Devices, Mobility & Transportation, New Materials, Robotics, Sector Agnostic.
- Where is Kairos Venture Investments, Llc located?
- Kairos Venture Investments, Llc is headquartered in Beverly Hills, US.
- Does Kairos Venture Investments, Llc lead rounds?
- Yes, Kairos Venture Investments, Llc leads investment rounds.
- Who does Kairos Venture Investments, Llc co-invest with?
- Kairos Venture Investments, Llc most often shares deals with Horizons Ventures, In-Q-Tel, Intel Capital, among 25 tracked co-investors.
Images
Similar investors
Khosla Ventures is a venture capital firm founded by Vinod Khosla.
Everywhere Ventures is an early-stage venture firm, backed by a community of founders and operators as LPs, that writes early checks (including pre-seed) into startups across many sectors and geographies.
Amadeus Capital Partners is a technology investment firm that backs founders building complex, science-led and deep tech businesses, supporting them over the long term as they scale internationally.
Snatched Ventures is a San Francisco-based early-stage venture capital firm backing DeepTech startups focused on sustainable innovation and operational transformation. It is led by a two-GP team combining corporate development and institutional investment management experience.
Quad Ventures is a Korean venture capital firm that identifies founders driving lifestyle and industry change and invests in the technologies enabling them, backing early-stage startups across advanced technology sectors.